Skip to main content

Digital Health (DH)

The Neural Analytics Lucid™ M1 transcranial Doppler Ultrasound System is indicated as an adjunct to the standard clinical practices for measuring and displaying cerebral blood flow velocity within the major conducting arteries and veins of the head and neck. Additionally, the Lucid™ M1 System measures the occurrence of transient emboli signals within the blood stream.

Technology topic

Digital Health (DH)

The Digital Health topic aims to support entrepreneurs and startups at the earliest-stages of development of innovative, differentiated and novel technologies that aim to improve physical or mental wellbeing or health, enable or assist individuals to increase or regain independence and quality of life and improve the delivery of healthcare including efficiency, reducing cost or improving outcomes.

Technologies in this portfolio include those applying AI in healthcare or general wellness (medical image analysis, personalized medicine, EHR/EMR, Clinical decision support, Computer aided diagnostics, support or therapy, smart/connected medical devices) as well as technologies that enable or provide assistance to aging or disabled populations and individuals undergoing rehabilitation.

Subtopics are not aimed at supporting or conducting clinical trials, clinical efficacy or safety studies, the development of pre-clinical or clinical-stage drug candidates or work performed primarily for regulatory data purposes.

Limited studies with human subjects may be acceptable to the extent that they are performed in support of feasibility or technological development.

Sub-Topics

DH1. Assistive, Enabling and Rehabilitative technologies
DH2. AI in healthcare and drug discovery
DH3. Healthcare Workflow, Economics and Delivery
DH4. Medical Diagnostics and Devices
DH5. Physical, Mental and Behavioral Health
DH6. Other Digital Health Technologies